Melissa Bordes
Family · San Antonio, TXNPI 1144904814
Payments from drug & device makers
Across 269 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$857
- Dexcom, Inc.$657
- Mannkind Corporation$553
- Novo Nordisk$480
- Tandem Diabetes Care, Inc.$441
- Lilly USA, LLC$430
- plus $3K from 22 others
What the payments were for
- Food & beverage$6,33299%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 33 | $857 |
| Dexcom, Inc. | 23 | $657 |
| Mannkind Corporation | 29 | $553 |
| Novo Nordisk | 30 | $480 |
| Tandem Diabetes Care, Inc. | 10 | $441 |
| Lilly USA, LLC | 20 | $430 |
| Cequr Corporation | 2 | $407 |
| Amgen | 24 | $379 |
| Boehringer Ingelheim | 13 | $344 |
| Sequel Med Tech, LLC | 16 | $271 |
| Novartis | 16 | $241 |
| Radius Health, Inc. | 5 | $214 |
| Averitas Pharma Inc. | 4 | $176 |
| Tolmar, Inc. | 9 | $173 |
| BETA Bionics, Inc. | 2 | $153 |
| Ascensia Diabetes Care US Inc. | 7 | $145 |
| Recordati_rare_diseases_inc. | 3 | $60 |
| AstraZeneca(2 entities) | 3 | $58 |
| Insulet Corporation | 3 | $55 |
| Amneal Pharmaceuticals LLC | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Antares Pharma, Inc. | 2 | $33 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
| GSK | 1 | $17 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$397
- Korlym$371
- t:slim X2 Insulin Pump with Control-IQ$360
- CeQur Simplicity$348
- DEXCOM G6 TRANSMITTER$233
- DEXCOM G7 GSS (161)$150
- DEXCOM STELO GLUCOSE BIOSENSOR$150
- Qutenza$147
- iLet Insulin Infusion Kit Inset$132
- iLet Insulin Infusion Kit Contact Detach$132
- JARDIANCE$125
- TWIIST$124
- MOUNJARO$122
- Tymlos$121
- AFREZZA$113
How this compares
$6,417 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 158 | $163,255 |
| OzempicSemaglutide | 126 | $132,499 |
| TrulicityDulaglutide | 22 | $32,386 |
| JardianceEmpagliflozin | 14 | $16,314 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $15,788 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 29 | $4,381 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $4,051 |
| HumalogInsulin Lispro | 11 | $3,659 |
| Novolog FlexpenInsulin Aspart | 16 | $3,032 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,472 |
| Levothyroxine Sodium | 57 | $400 |
| Atorvastatin Calcium | 26 | $178 |
| Pioglitazone Hcl | 11 | $89 |
| Metformin Hcl | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $430 | $199,300191 claims |
| Novo NordiskOzempic | $480 | $132,499126 claims |
| Boehringer IngelheimJardiance | $344 | $16,31414 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $55 | $40057 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.